|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 76.10 EUR | +0.45% |
|
-0.11% | +16.86% |
| 12-12 | India, France seal treaty revamp giving Paris dividend relief, Delhi tax rights | RE |
| 12-09 | DANONE : Gets a Neutral rating from Bernstein | ZD |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 23.62B | 24.28B | 27.66B | 27.62B | 27.38B | |||||
Total Revenues | 23.62B | 24.28B | 27.66B | 27.62B | 27.38B | |||||
Cost of Goods Sold, Total | 12.27B | 12.76B | 14.92B | 14.54B | 13.77B | |||||
Gross Profit | 11.35B | 11.52B | 12.74B | 13.08B | 13.61B | |||||
Selling General & Admin Expenses, Total | 7.65B | 7.84B | 8.93B | 9.04B | 9.5B | |||||
Stock-Based Compensation (IS) | - | - | - | - | - | |||||
R&D Expenses | 323M | 338M | 339M | 398M | 447M | |||||
Other Operating Expenses | 50M | 5M | 86M | 159M | 150M | |||||
Other Operating Expenses, Total | 8.02B | 8.19B | 9.36B | 9.59B | 10.1B | |||||
Operating Income | 3.33B | 3.34B | 3.38B | 3.49B | 3.51B | |||||
Interest Expense, Total | -358M | -323M | -308M | -513M | -600M | |||||
Interest And Investment Income | 151M | 156M | 155M | 341M | - | |||||
Net Interest Expenses | -207M | -167M | -153M | -172M | -600M | |||||
Income (Loss) On Equity Invest. | 304M | 585M | -32M | 36M | 30M | |||||
Other Non Operating Income (Expenses) | -104M | -95M | -157M | -185M | 220M | |||||
EBT, Excl. Unusual Items | 3.32B | 3.66B | 3.04B | 3.17B | 3.16B | |||||
Restructuring Charges | -216M | -1.03B | -419M | -103M | -322M | |||||
Merger & Related Restructuring Charges | - | - | - | - | - | |||||
Impairment of Goodwill | -32M | -7M | -400M | -47M | - | |||||
Gain (Loss) On Sale Of Assets | -4M | 8M | 2M | -1.13B | 310M | |||||
Asset Writedown | -321M | -45M | -258M | -48M | -51M | |||||
Other Unusual Items | 43M | -4M | -165M | -123M | -68M | |||||
EBT, Incl. Unusual Items | 2.79B | 2.58B | 1.8B | 1.72B | 3.03B | |||||
Income Tax Expense | 762M | 589M | 778M | 768M | 929M | |||||
Earnings From Continuing Operations | 2.03B | 1.99B | 1.02B | 953M | 2.1B | |||||
Net Income to Company | 2.03B | 1.99B | 1.02B | 953M | 2.1B | |||||
Minority Interest | -74M | -67M | -64M | -72M | -79M | |||||
Net Income - (IS) | 1.96B | 1.92B | 959M | 881M | 2.02B | |||||
Preferred Dividend and Other Adjustments | 15M | 26M | 13M | 8M | 4M | |||||
Net Income to Common Incl Extra Items | 1.94B | 1.9B | 946M | 873M | 2.02B | |||||
Net Income to Common Excl. Extra Items | 1.94B | 1.9B | 946M | 873M | 2.02B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 2.99 | 2.94 | 1.48 | 1.36 | 3.14 | |||||
Basic EPS - Continuing Operations | 2.99 | 2.94 | 1.48 | 1.36 | 3.14 | |||||
Basic Weighted Average Shares Outstanding | 649M | 646M | 639M | 641M | 643M | |||||
Net EPS - Diluted | 2.99 | 2.94 | 1.48 | 1.36 | 3.13 | |||||
Diluted EPS - Continuing Operations | 2.99 | 2.94 | 1.48 | 1.36 | 3.13 | |||||
Diluted Weighted Average Shares Outstanding | 650M | 646M | 639M | 642M | 644M | |||||
Normalized Basic EPS | 3.08 | 3.43 | 2.87 | 2.98 | 2.95 | |||||
Normalized Diluted EPS | 3.08 | 3.43 | 2.87 | 2.98 | 2.94 | |||||
Dividend Per Share | 1.94 | 1.94 | 2 | 2.1 | 2.15 | |||||
Payout Ratio | 70.81 | 67.67 | 129.09 | 145.18 | 66.7 | |||||
American Depositary Receipts Ratio (ADR) | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | |||||
Supplemental Items | ||||||||||
EBITDA | 4.42B | 4.54B | 4.25B | 4.75B | 4.36B | |||||
EBITA | 3.43B | 3.44B | 3.49B | 3.6B | 3.64B | |||||
EBIT | 3.33B | 3.34B | 3.38B | 3.49B | 3.51B | |||||
Effective Tax Rate - (Ratio) | 27.29 | 22.83 | 43.2 | 44.63 | 30.67 | |||||
Total Current Taxes | 799M | 663M | 738M | 814M | 868M | |||||
Total Deferred Taxes | -37M | -73M | 40M | -46M | 61M | |||||
Normalized Net Income | 2B | 2.22B | 1.84B | 1.91B | 1.9B | |||||
Interest on Long-Term Debt | 12M | 1M | 2M | - | - | |||||
Non-Cash Pension Expense | 21M | -21M | 26M | 32M | 41M | |||||
Supplemental Operating Expense Items | ||||||||||
Selling and Marketing Expenses | 5.37B | 5.52B | 6.29B | 6.29B | 6.57B | |||||
General and Administrative Expenses | 2.28B | 2.33B | 2.64B | 2.75B | 2.93B | |||||
Research And Development Expense From Footnotes | 323M | 338M | 339M | 398M | 447M | |||||
Stock-Based Comp., Other (Total) | 16M | 13M | 25M | 61M | 71M | |||||
Total Stock-Based Compensation | 16M | 13M | 25M | 61M | 71M |
- Stock Market
- Equities
- BN Stock
- Financials Danone
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















